70 related articles for article (PubMed ID: 3584516)
1. Low dose bromocriptine ameliorates hallucinations in a demented parkinsonian patient.
Sandyk R
J Clin Psychopharmacol; 1987 Apr; 7(2):114-5. PubMed ID: 3584516
[No Abstract] [Full Text] [Related]
2. Donepezil for dementia with Lewy bodies: a case study.
Aarsland D; Brønnick K; Karlsen K
Int J Geriatr Psychiatry; 1999 Jan; 14(1):69-72. PubMed ID: 10029938
[No Abstract] [Full Text] [Related]
3. Bromocriptine: long-term low-dose therapy in Parkinson's disease.
Teychenne PF; Bergsrud D; Elton RL; Racy A
Clin Neuropharmacol; 1986; 9(2):138-45. PubMed ID: 3708599
[TBL] [Abstract][Full Text] [Related]
4. Psychiatric effects of bromocriptine and lergotrile in Parkinsonian patients.
Serby M; Angrist B; Lieberman A
Adv Biochem Psychopharmacol; 1980; 23():287-92. PubMed ID: 6104908
[No Abstract] [Full Text] [Related]
5. [Use of bromocriptine in Parkinson diseases in low doses at a slow rate. 40 patients].
Liaño H; López-Lozano JJ; Ramírez A; Rabes C; Pascual ML
Arch Neurobiol (Madr); 1984; 47(3):143-50. PubMed ID: 6508478
[No Abstract] [Full Text] [Related]
6. Bromocriptine: problems with low-dose de novo therapy in Parkinson's disease.
Grimes JD; Delgado MR
Clin Neuropharmacol; 1985; 8(1):73-7. PubMed ID: 3978651
[TBL] [Abstract][Full Text] [Related]
7. Sydney Multicenter Study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years.
Hely MA; Morris JG; Reid WG; Trafficante R
Mov Disord; 2005 Feb; 20(2):190-9. PubMed ID: 15551331
[TBL] [Abstract][Full Text] [Related]
8. Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease.
Devos D;
Mov Disord; 2009 May; 24(7):993-1000. PubMed ID: 19253412
[TBL] [Abstract][Full Text] [Related]
9. Bromocriptine and lisuride in Parkinson disease.
Lieberman AN; Gopinathan G; Neophytides A; Leibowitz M; Walker R; Hiesiger E
Ann Neurol; 1983 Jan; 13(1):44-7. PubMed ID: 6830164
[TBL] [Abstract][Full Text] [Related]
10. Bromocriptine in Parkinson disease.
Lieberman AN; Goldstein M
Pharmacol Rev; 1985 Jun; 37(2):217-27. PubMed ID: 3901046
[TBL] [Abstract][Full Text] [Related]
11. Frontal dysfunction contributes to the genesis of hallucinations in non-demented Parkinsonian patients.
Grossi D; Trojano L; Pellecchia MT; Amboni M; Fragassi NA; Barone P
Int J Geriatr Psychiatry; 2005 Jul; 20(7):668-73. PubMed ID: 16021658
[TBL] [Abstract][Full Text] [Related]
12. [Neuropsychic side effects of bromocriptine in Parkinson's disease].
Simonetta M; Schmitt L; Montastruc JL; Rascol A
Rev Neurol (Paris); 1987; 143(8-9):608-11. PubMed ID: 3671965
[TBL] [Abstract][Full Text] [Related]
13. [Long-term results of treatment of Parkinson's disease with bromocriptine and domperidone (author's transl)].
Agid Y; Quinn N; Lhermitte F
Rev Neurol (Paris); 1981; 137(1):49-51. PubMed ID: 7232966
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of Parkinson disease by bromocriptine in the black African].
Ndiaye IP; Jacquin-Cotton L; Martini L
Dakar Med; 1980; 25(2):131-5. PubMed ID: 7215100
[No Abstract] [Full Text] [Related]
15. [Myoclonic attacks induced by bromocriptine in Parkinsonian patients].
Glaubman H; Rabey I; Vardi J
Harefuah; 1979 Jan; 96(2):90-2. PubMed ID: 478382
[No Abstract] [Full Text] [Related]
16. Further experiences with low doses of bromocriptine in Parkinson's disease.
Fahn S; Côté LJ; Barrett RE; Snider SR
Adv Biochem Psychopharmacol; 1980; 23():255-60. PubMed ID: 7395615
[No Abstract] [Full Text] [Related]
17. [Emotional and cognitive disorders in Parkinson disease].
Arsland D; Larsen JP
Tidsskr Nor Laegeforen; 1998 Oct; 118(25):3959-63. PubMed ID: 9830342
[TBL] [Abstract][Full Text] [Related]
18. Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease.
Burn D; Emre M; McKeith I; De Deyn PP; Aarsland D; Hsu C; Lane R
Mov Disord; 2006 Nov; 21(11):1899-907. PubMed ID: 16960863
[TBL] [Abstract][Full Text] [Related]
19. [Bromocriptine in Parkinson's disease. Personal experience].
Chacón JR; Piqueras L; Pery JM
Arch Neurobiol (Madr); 1982; 45(5):371-80. PubMed ID: 7165448
[No Abstract] [Full Text] [Related]
20. The role of bromocriptine in the treatment of Parkinson's disease.
Stern GM; Lees AJ; Shaw KM; Lander CM
Adv Biochem Psychopharmacol; 1980; 23():267-70. PubMed ID: 7395617
[No Abstract] [Full Text] [Related]
[Next] [New Search]
